| Diamond Hall (3F) | ||
| 14:00-14:10 | Opening Remark |
Seung Cheol Kim (Chairman of the Board, KSOG) |
| Session I: Maternal-Fetal Medicine | ¡¡
Chair: Pil Ryang Lee(Univ of Ulsan), Peng-Hui Wang(Taipei Veterans General Hospital) |
|
| 14:10-14:30 | Neurological outcomes and their correlation to fetal behavior patterns | Seiichi Morokuma(Kyushu Univ) |
| 14:30-14:50 | Impaired lymphangiogenic and immune cell trafficking function of decidual lymphatic endothelial cells in preeclampsia | Ja-Young Kwon(Yonsei Univ) |
| 14:50-15:10 | Exploring the immunological factors of preeclampsia | Chang-Ching Yeh(Taipei Veterans General Hospital) |
| Session II: Reproductive Endocrinology |
Chair: Jang Heub Kim(Catholic Kwandong Univ), Yu-Shih Yang(National Taiwan Univ) |
|
| 15:10-15:30 | Development of new Assisted Reproductive Technology (ART) and regenerative medicine based on regulating gene expression during preimplantation development | Mitsutoshi Yamada(Keio Univ) |
| 15:30-15:50 | Evidence-based postoperative management after endometrioma surgery: Samsung medical center experience | Doo-Seok Choi(Sungkyunkwan Univ) |
| 15:50-16:10 | Personalized ovarian stimulation for IVF: how to take both accessibility and success into considerations | Po-Wei Chu(Tri-Service General Hospital) |
| 16:10-16:30 | Coffee break | |
| Session III: Gynecologic Oncology |
Chair: Young-Tak Kim(Univ of Ulsan), Daisuke Aoki(Keio Univ) |
|
| 16:30-16:50 | Identification of novel therapeutic targets for ovarian cancer using large-scale RNAi functional screening | Masafumi Toyoshima(Tohoku Univ) |
| 16:50-17:10 | Current multicenter clinical trials in Korea - Introduction to KGOG | Chulmin Lee(Inje Univ) |
| 17:10-17:30 | BTLA can be a prognostic and therapeutic target in ovarian cancer | Yu-Li Chen(National Taiwan Univ) |